Ann: Change of Director's Interest Notice, page-19

First 19 Last

Share
Profile

Follow
jim4334

33 Posts.

21

27/04/19

19:15

Post #: 38289550
Share

Originally posted by jim4334: ↑

If the ship was genuinely sinking, why would you drop more in knowing you are going to lose? Sure, hope plays a massive part here, but hope isn't getting deals done, and you could argue fore and against deals getting done.

I believe that the IOT space in general is going to change the world. Buddy is a few years ahead of the general public IMO. Have a look at what 5G is going to do to the auto space. Every building in the world will in some way be encouraged to be smarter in one way or another. Building monitoring will be huge. I work in commercial property and NABERS is taken very seriously. You can't advertise a significant building without NABERS and there are fines if you do.

BUD IMO is ahead of its time. IF it can manage to stay afloat for a couple more years, the potential is enormous. DM has made mistakes, he has over promised and is yet to deliver. But that doesn't mean he can't. The team are getting deals done, we await a while or 3. If one lands, everything changes. If one doesn't, then we wait for volume to change it all.

IMO the change is coming. It's whether or not BUD will be at the forefront. But I'm backing my horse in, as I believe it has its nose at the front of the race. LIFX makes it all the more sweeter as the synergies are great.

I respect everyone's opinion here - both up and down - but I believe in my investment, albeit currently down a lot.

Expand

Also, I believe this 4C will be in line with the previous. anything over $900k would be inline with my expectations given Thor is back in. Anything less and we are going backward.

I encourage the thoughts of those with better understanding than I (read DPR, GB etc).

Cheers from the other side of the world

BUD Price at posting: 8.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

First 19 Last

Add BUD (ASX) to my watchlist

Ann: Change of Director's Interest Notice, page-19

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Cyclone signs MOU with Vale for development of Iron Bear play

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Featured News